Your browser doesn't support javascript.
loading
The Micro-Elimination Approach to Eliminating Hepatitis C: Strategic and Operational Considerations.
Lazarus, Jeffrey V; Safreed-Harmon, Kelly; Thursz, Mark R; Dillon, John F; El-Sayed, Manal H; Elsharkawy, Ahmed M; Hatzakis, Angelos; Jadoul, Michel; Prestileo, Tullio; Razavi, Homie; Rockstroh, Jürgen K; Wiktor, Stefan Z; Colombo, Massimo.
Afiliação
  • Lazarus JV; Barcelona Institute for Global Health (ISGlobal), Hospital Clínic, University of Barcelona, Barcelona, Spain.
  • Safreed-Harmon K; Barcelona Institute for Global Health (ISGlobal), Hospital Clínic, University of Barcelona, Barcelona, Spain.
  • Thursz MR; Department of Surgery and Cancer, Imperial College, London, United Kingdom.
  • Dillon JF; Division of Molecular and Clinical Medicine, School of Medicine, University of Dundee, Dundee, United Kingdom.
  • El-Sayed MH; Department of Pediatrics, Ain Shams University, Cairo, Egypt.
  • Elsharkawy AM; University Hospitals Birmingham, Mindelsohn Way, Birmingham, United Kingdom.
  • Hatzakis A; Department of Hygiene, Epidemiology and Medical Statistics, National and Kapodistrian University of Athens Medical School, Athens, Greece.
  • Jadoul M; Department of Nephrology, Cliniques universitaires Saint-Luc, Université catholique de Louvain, Brussels, Belgium.
  • Prestileo T; Infection Diseases Unit and Centre for Migration and Health, ARNAS, Civico-Benfratelli Hospital, Palermo, Italy.
  • Razavi H; Center for Disease Analysis Foundation, Lafayette, Colorado.
  • Rockstroh JK; Department of Medicine I, University of Bonn, Bonn, Germany.
  • Wiktor SZ; Department of Global Health, University of Washington Schools of Medicine and Public Health, Seattle, Washington.
  • Colombo M; Department of Medicine, Clinical and Research Center, Humanitas Hospital, Rozzano, Italy.
Semin Liver Dis ; 38(3): 181-192, 2018 08.
Article em En | MEDLINE | ID: mdl-29986353
ABSTRACT
The introduction of efficacious new hepatitis C virus (HCV) treatments galvanized the World Health Organization to define ambitious targets for eliminating HCV as a public health threat by 2030. Formidable obstacles to reaching this goal can best be overcome through a micro-elimination approach, which entails pursuing elimination goals in discrete populations through multi-stakeholder initiatives that tailor interventions to the needs of these populations. Micro-elimination is less daunting, less complex, and less costly than full-scale, country-level initiatives to eliminate HCV, and it can build momentum by producing small victories that inspire more ambitious efforts. The micro-elimination approach encourages stakeholders who are most knowledgeable about specific populations to engage with each other and also promotes the uptake of new models of care. Examples of micro-elimination target populations include medical patients, people who inject drugs, migrants, and prisoners, although candidate populations can be expected to vary greatly in different countries and subnational areas.
Assuntos

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Antivirais / Saúde Global / Hepatite C / Modelos Organizacionais / Prestação Integrada de Cuidados de Saúde / Erradicação de Doenças / Política de Saúde Tipo de estudo: Etiology_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Semin Liver Dis Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Espanha

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Antivirais / Saúde Global / Hepatite C / Modelos Organizacionais / Prestação Integrada de Cuidados de Saúde / Erradicação de Doenças / Política de Saúde Tipo de estudo: Etiology_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Semin Liver Dis Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Espanha